{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:37:00Z","timestamp":1790422620356,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.semarthrit.2020.06.005","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T11:41:06Z","timestamp":1592307666000},"page":"957-962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan"],"prefix":"10.1016","volume":"50","author":[{"given":"Chun-Yu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hua","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2020.06.005_bib0001","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Galie","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0002","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0039-1685214","article-title":"Pulmonary hypertension associated with connective tissue disease","volume":"40","author":"Fayed","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0003","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.rdc.2013.10.001","article-title":"Pulmonary arterial hypertension related to connective tissue disease: a review","volume":"40","author":"Ahmed","year":"2014","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/rheumatology\/kex291","article-title":"The British society for rheumatology guideline for the management of systemic lupus erythematosus in adults: executive summary","volume":"57","author":"Gordon","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0006","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0007","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/rheumatology\/kes140","article-title":"Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohort","volume":"51","author":"Shirai","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0008","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/1756-185X.12645","article-title":"Survival and prognostic factors in patients with connective tissue disease-associated pulmonary hypertension diagnosed by echocardiography: results from a Korean nationwide registry","volume":"20","author":"Kang","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0009","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1183\/09031936.00182813","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients","volume":"44","author":"Hao","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003579","article-title":"Prognostic factors in patients with pulmonary hypertension-a nationwide cohort study","volume":"5","author":"Chang","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0011","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.2018.0246","article-title":"Association of varicose veins with incident venous thromboembolism and peripheral artery disease","volume":"319","author":"Chang","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0012","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0013","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0014","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0016","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0017","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0018","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0019","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1183\/09031936.00138706","article-title":"Results of European post-marketing surveillance of bosentan in pulmonary hypertension","volume":"30","author":"Humbert","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0020","doi-asserted-by":"crossref","first-page":"00135","DOI":"10.1183\/23120541.00135-2017","article-title":"Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study","volume":"4","author":"Huang","year":"2018","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0021","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/acr.20683","article-title":"Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality","volume":"64","author":"Jakes","year":"2012","journal-title":"Arthritis Care. Res. (Hoboken)"},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0022","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s10067-013-2307-2","article-title":"Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature","volume":"32","author":"Yang","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0023","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis. Rheumatol."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0024","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13075-017-1250-z","article-title":"Australian Scleroderma Interest Group (ASIG). Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme","volume":"19","author":"Morrisroe","year":"2017","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0025","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann. Rheu. Dis."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01197-2017","article-title":"Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis","volume":"51","author":"Coghlan","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0027","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MD.0b013e3181579781","article-title":"Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature","volume":"86","author":"Launay","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2020.06.005_bib0028","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijcard.2017.01.097","article-title":"Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: a cohort study in China","volume":"236","author":"Zhao","year":"2017","journal-title":"Int. J. Cardiol."}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722030158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722030158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:03:54Z","timestamp":1758733434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901722030158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S004901722030158X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}